Other Species / Isoforms
  LBH (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S15-p
HCPDYLRsAKMTEVM
0 1
LBH (human) HCPDYLRsAKMTEVM S15-p
LBH (mouse) HCSDYLRSAEMTEVM S15
LBH (rat) HGSDYLRSAEMTEVM S16
S34-p
PMEEIGLsPRKDGLS
0 4
LBH (human) PMEEIGLsPRKDGLS S34-p
LBH (mouse) SMEEIGLSPRkDGLS S34
LBH (rat) SMEEIGLSPRKDGLS S35
K37
EIGLsPRKDGLSYQI
0 1
LBH (human) EIGLsPRKDGLSYQI K37
LBH (mouse) EIGLSPRkDGLSYQI K37-ub
LBH (rat) EIGLSPRKDGLSYQI K38
K58
FDRCCKLKDRLPsIV
0 1
LBH (human) FDRCCKLKDRLPsIV K58
LBH (mouse) FDRCCKLKDRLPsIV K58
LBH (rat) FDRCCKLkDRLPsIV K59-ac
S63-p
KLKDRLPsIVVEPtE
Upstream
0 362
Treatment
  • anti-CD3
  • EGF
  • SB202190
  • Su11274
  • U0126
LBH (human) KLKDRLPsIVVEPtE S63-p
LBH (mouse) KLKDRLPsIVVEPTE S63-p
LBH (rat) KLkDRLPsIVVEPTE S64-p
T69-p
PsIVVEPtEGEVEsG
0 5
LBH (human) PsIVVEPtEGEVEsG T69-p
LBH (mouse) PsIVVEPTEGEVESG T69
LBH (rat) PsIVVEPTEGEVESG T70
S75-p
PtEGEVEsGELRWPP
0 1
LBH (human) PtEGEVEsGELRWPP S75-p
LBH (mouse) PTEGEVESGELRWPP S75
LBH (rat) PTEGEVESGELRWPP S76